GREER MURPHY, MD
Psychiatric at Pasteur Dr, Palo Alto, CA
License number
California G64130
Category
Psychiatric
Type
Psychiatry
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 498-5710
Organization information
See more information about GREER MURPHY at bizstanding.comGreer Murphy MD,PHD
401 Quarry Rd, Palo Alto, CA 94304
Industry:
Psychiatrist
Phone:
(650) 724-4390 (Phone)
Greer Marechal Murphy Jr
Professional information
Greer M Murphy, Stanford CA
Specialties:
Psychiatrist
Address:
300 Pasteur Dr, Stanford, CA 94305
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Geriatric Psychiatry (Psychiatry and Neurology)
Dr. Greer Murphy, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Geriatric Psychiatry
Address:
Palo Alto Office
401 Quarry Rd, Palo Alto 94304
(650) 723-6643 (Phone)
401 Quarry Rd, Palo Alto 94304
(650) 723-6643 (Phone)
Languages:
English
Hospitals:
Palo Alto Office
401 Quarry Rd, Palo Alto 94304
Montefiore Medical Center - Wakefield
600 East 233Rd St, Bronx 10466
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
401 Quarry Rd, Palo Alto 94304
Montefiore Medical Center - Wakefield
600 East 233Rd St, Bronx 10466
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University Of California, Davis, School Of Medicine
Graduated: 1986
Stanford University Hospital
University Of California, Davis, School Of Medicine
Graduated: 1986
Stanford University Hospital
Methods And Compositions For Predicting Compliance With An Antidepressant Treatment Regimen
US Patent:
2005016, Jul 28, 2005
Filed:
Dec 9, 2004
Appl. No.:
11/010244
Inventors:
Greer Murphy - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Alan Schatzberg - Los Altos CA, US
International Classification:
A61K031/137, C12Q001/68
US Classification:
514649000, 435006000
Abstract:
Methods and compositions are provided for predicting whether a subject will comply with an antidepressant treatment regimen. In practicing the subject methods, a subject's serotonin transporter gene-linked polymorphic region (5HTTLPR) is genotyped. Based on the identified genotype, a particular antidepressant treatment regimen suitable for the patient is determined. Also provided are kits for practicing the subject methods.
Method To Determine The Risk For Side Effects Of An Ssri Treatment In A Person
US Patent:
2006022, Oct 12, 2006
Filed:
Jun 8, 2006
Appl. No.:
11/450212
Inventors:
Greer Murphy - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Alan Schatzberg - Los Altos CA, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
A new method is found to determine an increased risk for side effects of an SSRI treatment in a person by genotyping the person for the presence of the 102 C/C DNA sequence in the 5-HTreceptor gene. This provides for a method to improve the treatment of an SSRI responsive disorder and in particular depression.
Methods And Compositions For Predicting Compliance With An Antidepressant Treatment Regimen
US Patent:
2009019, Jul 30, 2009
Filed:
Mar 20, 2009
Appl. No.:
12/408539
Inventors:
Greer M. Murphy - Stanford CA, US
Alan F. Schatzberg - Los Altos CA, US
Alan F. Schatzberg - Los Altos CA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Methods and compositions are provided for predicting whether a subject will comply with an antidepressant treatment regimen. In practicing the subject methods, a subject's serotonin transporter gene-linked polymorphic region (5HTTLPR) is genotyped. Based on the identified genotype, a particular antidepressant treatment regimen suitable for the patient is determined. Also provided are kits for practicing the subject methods.
Methods And Compositions For Predicting Compliance With An Antidepressant Treatment Regimen
US Patent:
2009019, Aug 6, 2009
Filed:
Mar 20, 2009
Appl. No.:
12/408542
Inventors:
Greer M. Murphy - Stanford CA, US
Alan F. Schatzberg - Los Altos CA, US
Alan F. Schatzberg - Los Altos CA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Methods and compositions are provided for predicting whether a subject will comply with an antidepressant treatment regimen. In practicing the subject methods, a subject's serotonin transporter gene-linked polymorphic region (HTTLPR) is genotyped. Based on the identified genotype, a particular antidepressant treatment regimen suitable for the patient is determined. Also provided are kits for practicing the subject methods.
Method To Determine The Risk For Side Effects Of An Ssri Treatment In A Person
US Patent:
7951538, May 31, 2011
Filed:
Apr 9, 2009
Appl. No.:
12/421492
Inventors:
Greer M. Murphy - Stanford CA, US
Alan F. Schatzberg - Los Altos CA, US
Alan F. Schatzberg - Los Altos CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior Univeristy - Palo Alto CA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 912, 536 235, 536 2431
Abstract:
A new method is found to determine an increased risk for side effects of an SSRI treatment in a person by genotyping the person for the presence of the 102 C/C DNA sequence in the 5-HTreceptor gene. This provides for a method to improve the treatment of an SSRI responsive disorder and in particular depression.
Method To Determine The Risk For Side Effects Of An Ssri Treatment In A Person
US Patent:
8178299, May 15, 2012
Filed:
Apr 25, 2011
Appl. No.:
13/093113
Inventors:
Greer M. Murphy - Stanford CA, US
Alan F. Schatzberg - Los Altos CA, US
Alan F. Schatzberg - Los Altos CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 611, 435 61, 435 612, 435 613, 435 617, 435 912, 536 235, 536 2431
Abstract:
A new method is found to determine an increased risk for side effects of an SSRI treatment in a person by genotyping the person for the presence of the 102 C/C DNA sequence in the 5-HTreceptor gene. This provides for a method to improve the treatment of an SSRI responsive disorder and in particular depression.
Methods For Improving The Therapeutic Response Of Humans Having Major Depression And Carrying The Gene For Apolipoprotein E4
US Patent:
2003010, Jun 5, 2003
Filed:
Dec 3, 2001
Appl. No.:
10/010087
Inventors:
Greer Murphy - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Alan Schatzberg - Los Altos CA, US
International Classification:
A61K031/551, C12Q001/68
US Classification:
514/220000, 435/006000
Abstract:
This invention relates to a method for improving the therapeutic response of a human patient with major depression, characterised by genotyping said patient to be a carrier of the gene for apolipoprotein E4 and adapting the further treatment of the person differentially depending on the presence or absence of the said gene in the patient.
Genetic Polymorphisms Associated With Depression
US Patent:
2013024, Sep 19, 2013
Filed:
Nov 30, 2012
Appl. No.:
13/690928
Inventors:
The Board of Trustees of the Leland Stanford Junior University - , US
Laura C. Lazzeroni - Redwood City CA, US
Greer M. Murphy - Stanford CA, US
Jennifer Keller - Los Altos CA, US
Laura C. Lazzeroni - Redwood City CA, US
Greer M. Murphy - Stanford CA, US
Jennifer Keller - Los Altos CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 1/68
US Classification:
514178, 435 611, 536 2431
Abstract:
The present disclosure provides methods for determining risk for depression, as well as compositions for use in such methods.